Invention Grant
- Patent Title: NLRP3 modulators
-
Application No.: US17267516Application Date: 2019-08-15
-
Publication No.: US12024513B2Publication Date: 2024-07-02
- Inventor: Yong Zhang , Ashvinikumar V. Gavai
- Applicant: INNATE TUMOR IMMUNITY, INC.
- Applicant Address: US NJ Princeton
- Assignee: Innate Tumor Immunity, Inc.
- Current Assignee: Innate Tumor Immunity, Inc.
- Current Assignee Address: US NJ Princeton
- Agent Jing G. Sun
- International Application: PCT/US2019/046592 2019.08.15
- International Announcement: WO2020/037092A 2020.02.20
- Date entered country: 2021-02-10
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/00
Abstract:
The present invention provides compounds of Formula (I): wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).
Public/Granted literature
- US20210317118A1 NLRP3 MODULATORS Public/Granted day:2021-10-14
Information query
